| Date Filed | Type | Description |
| 08/11/2023 |
4
| Stewart Murray (Interim Chief Medical Officer) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 269,893 shares
@ $0
Sold 130,056 shares
@ $1.06, valued at
$137.9k
|
|
| 01/12/2023 |
4
| Stewart Murray (Director) has filed a Form 4 on AMARIN CORP PLC\UK|
Txns:
| Granted 223,560 options to buy
@ $1.48, valued at
$330.9k
Granted 182,433 options to buy
@ $0 |
|
| 01/12/2023 |
3
| Stewart Murray (Director) has filed a Form 3 on AMARIN CORP PLC\UK |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/21/2020 |
4
| Stewart Murray (Director) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 10,000 options to buy
@ $7.27, valued at
$72.7k
|
|
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
4
| Stewart Murray (Director) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 3,427 options to buy
@ $8.69, valued at
$29.8k
|
|
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2019 |
4
| Stewart Murray (Director) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 6,854 options to buy
@ $17.41, valued at
$119.3k
|
|
| 04/02/2019 |
3
| Stewart Murray (Director) has filed a Form 3 on X4 Pharmaceuticals, Inc |
| 02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/14/2018 |
4
| Stewart Murray (Executive Vice President, R&D) has filed a Form 4 on NOVELION THERAPEUTICS INC.|
Txns:
| Granted 45,000 options to buy
@ $0 |
|
| 11/29/2017 |
4
| Stewart Murray (Executive Vice President R&D) has filed a Form 4 on NOVELION THERAPEUTICS INC.|
Txns:
| Granted 50,000 shares
@ $0
Granted 200,000 options to buy
@ $0 |
|
| 11/29/2017 |
3
| Stewart Murray (Executive Vice President, R&D) has filed a Form 3 on NOVELION THERAPEUTICS INC. |